(Q46328629)

21 December 2017

title

Glycogen synthase kinase-3 inhibition by 3-anilino-4-phenylmaleimides: insights from 3D-QSAR and docking (English)

1 reference

21 December 2017

author

Pankaj Daga

2

1 reference

21 December 2017

author name string

Sivaprakasam Prasanna

1

1 reference

21 December 2017

Aihua Xie

3

1 reference

21 December 2017

Robert J Doerksen

4

1 reference

21 December 2017

publication date

7 October 2008

1 reference

21 December 2017

Journal of Computer - Aided Molecular Design

published in

1 reference

21 December 2017

volume

23

1 reference

21 December 2017

issue

2

1 reference

21 December 2017

page(s)

113-127

1 reference

21 December 2017

Multiple roles for glycogen synthase kinase-3 as a drug target in Alzheimer's disease

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10822-008-9244-1

21 January 2018

1 reference

12 December 2020

Glycogen synthase kinase-3: a target for novel bipolar disorder treatments.

1 reference

12 December 2020

GSK3beta signalling: casting a wide net in Alzheimer's disease

1 reference

12 December 2020

GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides

1 reference

12 December 2020

Structure based de novo design of novel glycogen synthase kinase 3 inhibitors

1 reference

12 December 2020

Kinase inhibitors for cardiovascular disease

1 reference

12 December 2020

Glycogen synthase kinase-3: properties, functions, and regulation

1 reference

12 December 2020

Plasmodium falciparum glycogen synthase kinase-3: molecular model, expression, intracellular localisation and selective inhibitors

1 reference

12 December 2020

Probing the physicochemical and structural requirements for glycogen synthase kinase-3alpha inhibition: 2D-QSAR for 3-anilino-4-phenylmaleimides

1 reference

12 December 2020

6-heteroaryl-pyrazolo[3,4-b]pyridines: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3).

1 reference

12 December 2020

PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer

1 reference

12 December 2020

Regulation of tau phosphorylation and protection against beta-amyloid-induced neurodegeneration by lithium. Possible implications for Alzheimer's disease

1 reference

12 December 2020

GSK-3 inhibitors: discoveries and developments

1 reference

12 December 2020

SAR and 3D-QSAR studies on thiadiazolidinone derivatives: exploration of structural requirements for glycogen synthase kinase 3 inhibitors.

1 reference

12 December 2020

3D QSAR studies on GSK-3 inhibition by aloisines.

1 reference

12 December 2020

Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification

1 reference

12 December 2020

3D-QSAR and molecular docking studies on pyrazolopyrimidine derivatives as glycogen synthase kinase-3beta inhibitors

1 reference

12 December 2020

Structure of GSK3beta reveals a primed phosphorylation mechanism

1 reference

12 December 2020

Glycogen synthase kinase 3: a drug target for CNS therapies

1 reference

12 December 2020

Glycogen synthase kinase-3 in neurodegeneration and neuroprotection: lessons from lithium

1 reference

12 December 2020

Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins

1 reference

12 December 2020

Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics

1 reference

12 December 2020

5-aryl-pyrazolo[3,4-b]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3)

1 reference

12 December 2020

3D QSAR for GSK-3beta inhibition by indirubin analogues

1 reference

12 December 2020

3D-QSAR and docking studies of selective GSK-3beta inhibitors. Comparison with a thieno[2,3-b]pyrrolizinone derivative, a new potential lead for GSK-3beta ligands.

1 reference

12 December 2020

Inhibition of GSK-3beta as a target for cardioprotection: the importance of timing, location, duration and degree of inhibition

1 reference

12 December 2020

Protein kinases as targets for antimalarial intervention: Kinomics, structure-based design, transmission-blockade, and targeting host cell enzymes

1 reference

12 December 2020

3-Anilino-4-arylmaleimides: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3).

1 reference

12 December 2020

Discovery and development of GSK3 inhibitors for the treatment of type 2 diabetes

1 reference

12 December 2020

Regulation and function of glycogen synthase kinase-3 isoforms in neuronal survival

1 reference

12 December 2020

Inhibitory mode of N-phenyl-4-pyrazolo[1,5-b] pyridazin-3-ylpyrimidin-2-amine series derivatives against GSK-3: molecular docking and 3D-QSAR analyses

1 reference

12 December 2020

QSAR modeling of the inhibition of glycogen synthase kinase-3.

1 reference

12 December 2020

A fast flexible docking method using an incremental construction algorithm.

1 reference

12 December 2020

6-aryl-pyrazolo[3,4-b]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3).

1 reference

12 December 2020

1 reference

12 December 2020

5-aryl-pyrazolo[3,4-b]pyridazines: potent inhibitors of glycogen synthase kinase-3 (GSK-3).

1 reference

12 December 2020

Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription

1 reference

12 December 2020

New leads for selective GSK-3 inhibition: pharmacophore mapping and virtual screening studies

1 reference

12 December 2020

Investigation of potential glycogen synthase kinase 3 inhibitors using pharmacophore mapping and virtual screening.

1 reference

12 December 2020

Inactivation of glycogen synthase kinase-3beta, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells

1 reference

12 December 2020

Role of glycogen synthase kinase-3 in cancer: regulation by Wnts and other signaling pathways

1 reference

12 December 2020

Clustal W and Clustal X version 2.0

1 reference

12 December 2020

Structural characterization of the GSK-3beta active site using selective and non-selective ATP-mimetic inhibitors

1 reference

12 December 2020

QSAR studies for the pharmacological inhibition of glycogen synthase kinase-3.

1 reference

12 December 2020

10.1007/S10822-008-9244-1

Identifiers

DOI

1 reference

21 December 2017

journals/jcamd/PrasannaDXD09

DBLP publication ID

1 reference

DBLP Dataset 2021-01-02

28 January 2021

1 reference

21 December 2017